allied
academies
Page 14
Notes:
Journal of Clinical Pathology and Laboratory Medicine | Volume 3
July 05-06, 2019 | Paris, France
Pathology and Surgical Pathology
2
nd
International Conference on
C
ancer affects everyone - the young and old, the rich and
poor, men, women and children, about 16% of people die
from cancer, in 2015, 8.8 million people died from cancer-
nearly 1 in 6 global deaths (WHO). The total economic cost
of cancer in 2010 was estimated at approximately $1.16
Trillion. Cancer defined as a disease in which a group of
abnormal cells growuncontrollably the normal cell of division,
continue and spread, it can be fatal, we now define cancer
as a disease involves mutations in the cell genome (DNA
mutations), cancer starts in just one cell, so early laboratory
diagnosis of cancer is very important, ordinary tumor markers
are not enough and using 400-gene test for cancer is difficult
and limited in medical laboratory, miRNAs biomarkers
have become as key molecular components of the cell in
both normal and pathologic states, each tumor type has a
distinct miRNA signature, now there are over 2500 human
miRNAs recorded, the purpose of this work is to design a
one laboratory test for early diagnosis of cancer using small
group of miRNAs as one panel, which need blood sample less
than 1 ml by which patient can check up for many types of
cancer, can do population screening, diagnosis, prognosis,
therapeutic decision making and disease monitoring.
Speaker Biography
Ahmed Abdelhalim Yameny is the head of society of pathological
biochemistry and hematology. He is the chairman of Medical Laboratory
Syndicate in Egypt. He was the chairman for five international conferences
of medical laboratory and four international conferences of the society of
pathological biochemistry and hematology. He is an expert and medical
laboratory consultant. He is chief editor of Journal of Bioscience and
Applied Research; International Journal of Pathology and Biomarkers and
Journal of Medical and Life Science. He has a PhD in Microbiology and has
five high diplomas (bacteriology, public health of parasitology and medical
entomology, analytical biochemistry, hematology and genetic analysis). He
has a BSc in Biochemistry (Alexandria University in Egypt) and he has a BSc
in Biochemistry/Chemistry (Tanta University in Egypt). He is a researcher
and interested in molecular pathology.
e:
dr.ahmedyameny@yahoo.comAhmed Abdelhalim Yameny
Society of Pathological Biochemistry and Hematology, Egypt
The role of miRNA in early cancer diagnosis